David Linetsky Phreesia, Inc. (PHR) insider trading activity

David Linetsky is SVP, Life Sciences of Phreesia, Inc.. Currently has a direct ownership of 218,135 shares of PHR, which is worth approximately $5.67 Million. The most recent transaction as insider was on Nov 05, 2021, when has been sold 3,478 shares (Common Stock) at a price of $75.15 per share, resulting in proceeds of $261,372. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 218K

15.81% 3M change

6.9% 12M change

Total Value Held $5.67 Million

David Linetsky Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 05 2021	SELL Open market or private sale	$261,372 $75.15 p/Share	3,478 Reduced 2.42%	140,388 Common Stock
Nov 05 2021	BUY Exercise of conversion of derivative security	$16,381 $4.71 p/Share	3,478 Added 2.36%	143,866 Common Stock
Nov 01 2021	SELL Open market or private sale	$386,094 $70.83 p/Share	5,451 Reduced 3.74%	140,388 Common Stock
Nov 01 2021	BUY Exercise of conversion of derivative security	$25,674 $4.71 p/Share	5,451 Added 3.6%	145,839 Common Stock
Oct 15 2021	SELL Open market or private sale	$356,343 $65.36 p/Share	5,452 Reduced 3.74%	140,388 Common Stock
Oct 15 2021	BUY Exercise of conversion of derivative security	$25,679 $4.71 p/Share	5,452 Added 3.6%	145,840 Common Stock
Sep 01 2021	SELL Open market or private sale	$351,248 $70.56 p/Share	4,978 Reduced 3.42%	140,388 Common Stock
Sep 01 2021	BUY Exercise of conversion of derivative security	$23,446 $4.71 p/Share	4,978 Added 3.31%	145,366 Common Stock
Aug 31 2021	SELL Open market or private sale	$34,052 $71.84 p/Share	474 Reduced 0.34%	140,388 Common Stock
Aug 31 2021	BUY Exercise of conversion of derivative security	$2,233 $4.71 p/Share	474 Added 0.34%	140,862 Common Stock
Aug 27 2021	SELL Open market or private sale	$1,542,400 $71.89 p/Share	21,455 Reduced 13.26%	140,388 Common Stock
Aug 27 2021	BUY Exercise of conversion of derivative security	$54,710 $2.55 p/Share	21,455 Added 11.7%	161,843 Common Stock
Aug 26 2021	SELL Open market or private sale	$56,056 $70.07 p/Share	800 Reduced 0.57%	140,388 Common Stock
Aug 26 2021	BUY Exercise of conversion of derivative security	$2,040 $2.55 p/Share	800 Added 0.56%	141,188 Common Stock
Aug 25 2021	SELL Open market or private sale	$35,020 $70.04 p/Share	500 Reduced 0.35%	140,388 Common Stock
Aug 25 2021	BUY Exercise of conversion of derivative security	$1,275 $2.55 p/Share	500 Added 0.35%	140,888 Common Stock
May 04 2021	BUY Exercise of conversion of derivative security	$65,534 $1.44 p/Share	45,510 Added 24.48%	140,388 Common Stock
Mar 16 2021	SELL Open market or private sale	$94,917 $60.15 p/Share	1,578 Reduced 1.68%	92,580 Common Stock
Mar 15 2021	SELL Open market or private sale	$2,975,825 $61.38 p/Share	48,482 Reduced 33.99%	94,158 Common Stock
Jan 20 2021	SELL Open market or private sale	$447,103 $65.5 p/Share	6,826 Reduced 4.57%	142,640 Common Stock
Jan 19 2021	SELL Open market or private sale	$330,142 $64.28 p/Share	5,136 Reduced 3.32%	149,466 Common Stock
Jan 17 2021	SELL Payment of exercise price or tax liability	$17,440 $62.96 p/Share	277 Reduced 0.18%	154,602 Common Stock
Jan 15 2021	SELL Payment of exercise price or tax liability	$112,510 $62.96 p/Share	1,787 Reduced 1.14%	154,879 Common Stock
Jan 15 2021	BUY Grant, award, or other acquisition	-	28,589 Added 15.43%	156,666 Common Stock
Oct 01 2020	SELL Open market or private sale	$140,488 $31.38 p/Share	4,477 Reduced 3.38%	128,077 Common Stock

David Linetsky

SVP, Life Sciences

Raleigh, NC

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PHR shares.

Notify only if

Value

Insider Trading

Get notified when an Phreesia, Inc. insider buys or sells PHR shares.

Notify only if

Operation

Value

Type

News

Receive news related to Phreesia, Inc.

Track Activities on PHR

Account